- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1873-961X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells ; day:8 ; month:3 ; year:2019 ; pages:1-12
Journal of cell communication and signaling ; (8.3.2019), 1-12
- Urheber
-
Ciołczyk-Wierzbicka, Dorota
Zarzycka, Marta
Gil, Dorota
Laidler, Piotr
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12079-019-00510-0
- URN
-
urn:nbn:de:101:1-2019040221090696333997
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ciołczyk-Wierzbicka, Dorota
- Zarzycka, Marta
- Gil, Dorota
- Laidler, Piotr
- SpringerLink (Online service)
Ähnliche Objekte (12)
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
Correction to: Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Combined application of a natural HDAC inhibitor sulforaphane with the mTOR inhibitor everolimus in the therapy of bladder cancer
The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat
Apoptosis & senescence : cell fate determination in inhibitor-treated melanoma cells
Apoptosis & senescence: cell fate determination in inhibitor-treated melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
Correction to: Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Combined application of a natural HDAC inhibitor sulforaphane with the mTOR inhibitor everolimus in the therapy of bladder cancer
The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat
Apoptosis & senescence : cell fate determination in inhibitor-treated melanoma cells
Apoptosis & senescence: cell fate determination in inhibitor-treated melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
Correction to: Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Combined application of a natural HDAC inhibitor sulforaphane with the mTOR inhibitor everolimus in the therapy of bladder cancer
The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat
Apoptosis & senescence : cell fate determination in inhibitor-treated melanoma cells
Apoptosis & senescence: cell fate determination in inhibitor-treated melanoma cells